Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$206K Sell
2,102
-6,744
-76% -$594K 0.14% 192
2020
Q1
$674K Buy
+8,846
New +$753K 0.53% 35
2019
Q2
Sell
-7,029
Closed -$566K 321
2019
Q1
$566K Buy
+7,029
New +$575K 0.18% 100
2018
Q2
Sell
-3,389
Closed -$321K 390
2018
Q1
$321K Buy
+3,389
New +$372K 0.03% 241
2016
Q2
Sell
-5,258
Closed -$320K 642
2016
Q1
$300K Sell
5,258
-2,445
-32% -$136K 0.01% 448
2015
Q4
$456K Buy
+7,703
New +$444K 0.01% 468
2015
Q2
Sell
-11,821
Closed -$772K 1083
2015
Q1
$692K Buy
11,821
+10,654
+913% +$644K 0.02% 326
2014
Q4
$76K Sell
1,167
-6,202
-84% -$391K ﹤0.01% 818
2014
Q3
$426K Buy
7,369
+6,489
+737% +$360K 0.01% 431
2014
Q2
$50K Buy
+880
New +$46.2K ﹤0.01% 704
2014
Q1
Sell
-3,538
Closed -$187K 721
2013
Q4
$187K Buy
+3,538
New +$174K 0.02% 535

Other funds holding ABBV

Jump Trading's ABBV Position: Q2 2020 in Review

Jump Trading reduced its AbbVie (ABBV) stake by 76% in Q2 2020, selling an estimated $594K and leaving 2,102 shares worth $206K. The position accounts for 0.14% of the portfolio, ranked #192.

Jump Trading first reported a position in ABBV in Q4 2013 and has held it in 11 quarters since. The position peaked at $692K in Q1 2015. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Jump Trading held 2,102 shares of AbbVie worth $206K as of Q2 2020.
  • Jump Trading sold 6,744 AbbVie shares in Q2 2020, an estimated $594K.
  • AbbVie made up 0.14% of Jump Trading's portfolio in Q2 2020, its #192 holding.
  • Jump Trading first reported a position in AbbVie in Q4 2013 and has held it in 11 quarters since.
  • Jump Trading's AbbVie position peaked at $692K in Q1 2015.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.